184 related articles for article (PubMed ID: 38207211)
1. IL-1β promotes MPN disease initiation by favoring early clonal expansion of JAK2-mutant hematopoietic stem cells.
Rai S; Zhang Y; Grockowiak E; Kimmerlin Q; Hansen N; Stoll CB; Usart M; Luque Paz D; Hao-Shen H; Zhu Y; Roux J; Bader MS; Dirnhofer S; Farady CJ; Schroeder T; Méndez-Ferrer S; Skoda RC
Blood Adv; 2024 Mar; 8(5):1234-1249. PubMed ID: 38207211
[TBL] [Abstract][Full Text] [Related]
2. Loss of Dnmt3a increases self-renewal and resistance to pegIFN-α in JAK2-V617F-positive myeloproliferative neoplasms.
Usart M; Stetka J; Luque Paz D; Hansen N; Kimmerlin Q; Almeida Fonseca T; Lock M; Kubovcakova L; Karjalainen R; Hao-Shen H; Börsch A; El Taher A; Schulz J; Leroux JC; Dirnhofer S; Skoda RC
Blood; 2024 Jun; 143(24):2490-2503. PubMed ID: 38493481
[TBL] [Abstract][Full Text] [Related]
3. Myeloproliferative neoplasms can be initiated from a single hematopoietic stem cell expressing JAK2-V617F.
Lundberg P; Takizawa H; Kubovcakova L; Guo G; Hao-Shen H; Dirnhofer S; Orkin SH; Manz MG; Skoda RC
J Exp Med; 2014 Oct; 211(11):2213-30. PubMed ID: 25288396
[TBL] [Abstract][Full Text] [Related]
4. JAK2-V617F and interferon-α induce megakaryocyte-biased stem cells characterized by decreased long-term functionality.
Rao TN; Hansen N; Stetka J; Luque Paz D; Kalmer M; Hilfiker J; Endele M; Ahmed N; Kubovcakova L; Rybarikova M; Hao-Shen H; Geier F; Beisel C; Dirnhofer S; Schroeder T; Brümmendorf TH; Wolf D; Koschmieder S; Skoda RC
Blood; 2021 Apr; 137(16):2139-2151. PubMed ID: 33667305
[TBL] [Abstract][Full Text] [Related]
5. Loss of Ezh2 synergizes with JAK2-V617F in initiating myeloproliferative neoplasms and promoting myelofibrosis.
Shimizu T; Kubovcakova L; Nienhold R; Zmajkovic J; Meyer SC; Hao-Shen H; Geier F; Dirnhofer S; Guglielmelli P; Vannucchi AM; Feenstra JD; Kralovics R; Orkin SH; Skoda RC
J Exp Med; 2016 Jul; 213(8):1479-96. PubMed ID: 27401344
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of interleukin-1β reduces myelofibrosis and osteosclerosis in mice with JAK2-V617F driven myeloproliferative neoplasm.
Rai S; Grockowiak E; Hansen N; Luque Paz D; Stoll CB; Hao-Shen H; Mild-Schneider G; Dirnhofer S; Farady CJ; Méndez-Ferrer S; Skoda RC
Nat Commun; 2022 Sep; 13(1):5346. PubMed ID: 36100613
[TBL] [Abstract][Full Text] [Related]
7. Deletion of Stat3 in hematopoietic cells enhances thrombocytosis and shortens survival in a JAK2-V617F mouse model of MPN.
Grisouard J; Shimizu T; Duek A; Kubovcakova L; Hao-Shen H; Dirnhofer S; Skoda RC
Blood; 2015 Mar; 125(13):2131-40. PubMed ID: 25595737
[TBL] [Abstract][Full Text] [Related]
8. Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms.
Arranz L; Sánchez-Aguilera A; Martín-Pérez D; Isern J; Langa X; Tzankov A; Lundberg P; Muntión S; Tzeng YS; Lai DM; Schwaller J; Skoda RC; Méndez-Ferrer S
Nature; 2014 Aug; 512(7512):78-81. PubMed ID: 25043017
[TBL] [Abstract][Full Text] [Related]
9. Effects of JAK1/2 inhibition on bone marrow stromal cells of myeloproliferative neoplasm (MPN) patients and healthy individuals.
Zacharaki D; Ghazanfari R; Li H; Lim HC; Scheding S
Eur J Haematol; 2018 Jul; 101(1):57-67. PubMed ID: 29645296
[TBL] [Abstract][Full Text] [Related]
10. JAK2
Lin CH; Kaushansky K; Zhan H
Blood Cells Mol Dis; 2016 Nov; 62():42-48. PubMed ID: 27865175
[TBL] [Abstract][Full Text] [Related]
11. A role for reactive oxygen species in JAK2 V617F myeloproliferative neoplasm progression.
Marty C; Lacout C; Droin N; Le Couédic JP; Ribrag V; Solary E; Vainchenker W; Villeval JL; Plo I
Leukemia; 2013 Nov; 27(11):2187-95. PubMed ID: 23558526
[TBL] [Abstract][Full Text] [Related]
12. JAK2V617F expression in mice amplifies early hematopoietic cells and gives them a competitive advantage that is hampered by IFNα.
Hasan S; Lacout C; Marty C; Cuingnet M; Solary E; Vainchenker W; Villeval JL
Blood; 2013 Aug; 122(8):1464-77. PubMed ID: 23863895
[TBL] [Abstract][Full Text] [Related]
13. JAK2
Zhan H; Ma Y; Lin CH; Kaushansky K
Leukemia; 2016 Dec; 30(12):2332-2341. PubMed ID: 27133820
[TBL] [Abstract][Full Text] [Related]
14. The PIM inhibitor AZD1208 synergizes with ruxolitinib to induce apoptosis of ruxolitinib sensitive and resistant JAK2-V617F-driven cells and inhibit colony formation of primary MPN cells.
Mazzacurati L; Lambert QT; Pradhan A; Griner LN; Huszar D; Reuther GW
Oncotarget; 2015 Nov; 6(37):40141-57. PubMed ID: 26472029
[TBL] [Abstract][Full Text] [Related]
15. Hmga2 collaborates with
Ueda K; Ikeda K; Ikezoe T; Harada-Shirado K; Ogawa K; Hashimoto Y; Sano T; Ohkawara H; Kimura S; Shichishima-Nakamura A; Nakamura Y; Shikama Y; Mori T; Mason PJ; Bessler M; Morishita S; Komatsu N; Shide K; Shimoda K; Koide S; Aoyama K; Oshima M; Iwama A; Takeishi Y
Blood Adv; 2017 Jun; 1(15):1001-1015. PubMed ID: 29296743
[TBL] [Abstract][Full Text] [Related]
16. Identification of oncostatin M as a JAK2 V617F-dependent amplifier of cytokine production and bone marrow remodeling in myeloproliferative neoplasms.
Hoermann G; Cerny-Reiterer S; Herrmann H; Blatt K; Bilban M; Gisslinger H; Gisslinger B; Müllauer L; Kralovics R; Mannhalter C; Valent P; Mayerhofer M
FASEB J; 2012 Feb; 26(2):894-906. PubMed ID: 22051730
[TBL] [Abstract][Full Text] [Related]
17. Contributions of bone marrow monocytes/macrophages in myeloproliferative neoplasms with JAK2
Fan W; Cao W; Shi J; Gao F; Wang M; Xu L; Wang F; Li Y; Guo R; Bian Z; Li W; Jiang Z; Ma W
Ann Hematol; 2023 Jul; 102(7):1745-1759. PubMed ID: 37233774
[TBL] [Abstract][Full Text] [Related]
18. TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms.
Fleischman AG; Aichberger KJ; Luty SB; Bumm TG; Petersen CL; Doratotaj S; Vasudevan KB; LaTocha DH; Yang F; Press RD; Loriaux MM; Pahl HL; Silver RT; Agarwal A; O'Hare T; Druker BJ; Bagby GC; Deininger MW
Blood; 2011 Dec; 118(24):6392-8. PubMed ID: 21860020
[TBL] [Abstract][Full Text] [Related]
19. [Construction of a Mouse Model for Myeloproliferative Neoplasms and an Evaluation System].
Wang SJ; Yu XR; Zhang QG; Li YJ; Fu CL; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1113-1118. PubMed ID: 37551485
[TBL] [Abstract][Full Text] [Related]
20. Phenformin increases early hematopoietic progenitors in the Jak2
Alves-Silva AB; Fenerich BA; Fonseca NP; Fernandes JC; Coelho-Silva JL; Pereira-Martins DA; Bianco TM; Scheucher PS; Rego EM; Chahud F; Machado-Neto JA; Figueiredo-Pontes LL; Traina F
Invest New Drugs; 2022 Jun; 40(3):576-585. PubMed ID: 35015172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
